Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *


Products » Items » Grofenac Retard


Contraindicated
Foetal cardiopulmonary toxicity & renal dysfunction. Inhibition of uterine contractions

Contraindicated
Grofenac Retard :
Type Medicine Authorised
Originator Xenid Tablets 100mg*
Agent Mediterranean Pharmaceutical Company
Distributor Mediterranean Pharmaceutical Company
Laboratory Dr Grossmann
Responsible Party Dr Grossmann AG Pharmaca
Origin Switzerland
Manufacturer Dr Grossmann
Manufacturing Type G
Origin Switzerland
ATC M01AB05

Your comment will appear shortly after approval


Different Units By MoH Code

Revision Date :

Grofenac Retard  MoH 1277 :
Form Tablet, Prolonged-release
Package Size Box of 10
Strength 100mg
Public Price 260705.44 L.L.
Stratum A1
NSSF
Quarantine
Reg. Number 27795
Submission date 01/01/1997
Registration Year 1997
Barcode 7680477020119





Price Comparison

Country: Lebanon
Form: Tablet, Prolonged-release
Package Size: Box of 10
Public Price: 260705.44 LBP ( 260,705.44 LBP )
Pack size unit used: 10
Cost/Unit: 26070,54 LBP ( 26,070.00 LBP )
Pricing Date: 13/06/2024

Country: Oman
Package Size: 10
Public Price: 1.87 OMR ( 431,472.58 LBP )
Pack size unit used: 10
Cost/Unit: 0,187 OMR ( 0.00 LBP )
Pricing Date: 19/02/2021
Type: Medicine Authorised

Country: Switzerland
Package Size: 10
Public Price: 7.7 CHF ( 796,334.00 LBP )
Pack size unit used: 10
Cost/Unit: 0,77 CHF ( 0.00 LBP )
Exfactory Price: 3.15 CHF
Pricing Date: 04/04/2021
Type: Medicine Authorised

Country: Kuweit
Package Size: Boîte de 10
Public Price: 1.42 KWD ( 416,885.02 LBP )
Pack size unit used: 10
Cost/Unit: 0,142 KWD ( 0.00 LBP )
Pharmacy Price: 1.2 KWD ( 352297.2 LBP )
Pricing Date: 07/02/2021
Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info